CIBC raised the firm’s price target on Nutrien (NTR) to $66 from $64 and keeps an Outperformer rating on the shares. The firm cites increased ...
In a report released today, Mark Petrie from CIBC maintained a Buy rating on Alimentation Couche-Tard Inc (ATD – Research Report), with a price ...
CIBC Asset Management Inc grew its holdings in GameStop Corp. (NYSE:GME – Free Report) by 5.7% in the fourth quarter, ...
CIBC Asset Management Inc lifted its stake in Globus Medical, Inc. (NYSE:GMED – Free Report) by 5.3% in the fourth quarter, ...
The stock has been on fire since late last year, but CIBC analyst Todd Coupland thinks there is still money to be made on ...
"CLUE," the hilarious murder mystery comedy inspired by the Hasbro board game and adapted from the fan-favorite film, is ...
Clue, or Cluedo in the country of its birth, is one of the best board games of all time. Colonel Mustard, Mrs. Peacock and ...
Sanctuary Wealth's latest minority investment marks a new phase in the RIA aggregator's efforts to support independent ...
Royal Bank of Canada ( TSX:RY) and Canadian Imperial Bank of Commerce ( TSX:RY) are two of Canada’s largest financial ...
5don MSN
CIBC (TSX:CM) stock looks like a great bargain for 2025 and beyond. The post Outlook for CIBC Stock in 2025 appeared first on ...
As previously reported, CIBC upgraded Capital Power (CPXWF) to Outperformer from Neutral with a price target of C$64, down ...
7d
Hosted on MSNCIBC Upgrades TransAlta (TAC)Fintel reports that on February 18, 2025, CIBC upgraded their outlook for TransAlta (NYSE:TAC) from Neutral to Outperformer.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results